Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Edesa Biotech, Inc. Common Shares, without par value (EDSA).
- Disclosed ownership: 7.2%.
- Date of event: 24 Feb 2026.
Point72 Asset Management, L.P. - 24 Feb 2026 SCHEDULE 13G Report for Edesa Biotech, Inc. Common Shares, without par value (EDSA)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- EDSA
- Shares outstanding
- 8,333,333 shares
- Disclosed Ownership
- 600,000 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Mar 2026, 16:25:15 UTC
- Date of event
- 24 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 7.2% ownership in Edesa Biotech, Inc. Common Shares, without par value (EDSA) on 24 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Mar 2026, 16:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 7.2% | 600,000 | 0 | 600,000 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 7.2% | 600,000 | 0 | 600,000 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 7.2% | 600,000 | 0 | 600,000 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |